| Neuropathological features of Covid-19 IH Solomon, E Normandin, S Bhattacharyya, SS Mukerji, K Keller, AS Ali, ... New England Journal of Medicine 383 (10), 989-992, 2020 | 910 | 2020 |
| Global incidence of neurological manifestations among patients hospitalized with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY consortium SHY Chou, E Beghi, R Helbok, E Moro, J Sampson, V Altamirano, ... JAMA network open 4 (5), e2112131-e2112131, 2021 | 376 | 2021 |
| What can we learn from brain autopsies in COVID-19? SS Mukerji, IH Solomon Neuroscience letters 742, 135528, 2021 | 175 | 2021 |
| Multisystem involvement in post‐acute sequelae of coronavirus disease 19 P Novak, SS Mukerji, HS Alabsi, D Systrom, SP Marciano, D Felsenstein, ... Annals of neurology 91 (3), 367-379, 2022 | 96 | 2022 |
| Skeletal muscle and peripheral nerve histopathology in COVID-19 J Suh, SS Mukerji, SI Collens, RF Padera Jr, GS Pinkus, AA Amato, ... Neurology 97 (8), e849-e858, 2021 | 87 | 2021 |
| Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19 J Conklin, MP Frosch, SS Mukerji, O Rapalino, MD Maher, PW Schaefer, ... Journal of the neurological sciences 421, 117308, 2021 | 78 | 2021 |
| Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice SS Mukerji, EA Katsman, C Wilber, NA Haner, WR Selman, AK Hall Journal of Cerebral Blood Flow & Metabolism 27 (6), 1161-1172, 2007 | 74 | 2007 |
| Post-acute neurological consequences of COVID-19: an unequal burden LST Nolen, SS Mukerji, NI Mejia Nature Medicine 28 (1), 20-23, 2022 | 67 | 2022 |
| Neurologic manifestations of the World Health Organization's list of pandemic and epidemic diseases CRS McEntire, KW Song, RP McInnis, JY Rhee, M Young, E Williams, ... Frontiers in Neurology 12, 634827, 2021 | 56 | 2021 |
| Rapid detection of Powassan virus in a patient with encephalitis by metagenomic sequencing A Piantadosi, S Kanjilal, V Ganesh, A Khanna, EP Hyle, J Rosand, T Bold, ... Clinical Infectious Diseases 66 (5), 789-792, 2018 | 56 | 2018 |
| Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults SS Mukerji, V Misra, D Lorenz, AM Cervantes-Arslanian, J Lyons, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 75 (2), 246-255, 2017 | 54 | 2017 |
| Development and prospective validation of a deep learning algorithm for predicting need for mechanical ventilation SP Shashikumar, G Wardi, P Paul, M Carlile, LN Brenner, KA Hibbert, ... Chest 159 (6), 2264-2273, 2021 | 53 | 2021 |
| Impact of antiretroviral regimens on cerebrospinal fluid viral escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency virus-1 … SS Mukerji, V Misra, DR Lorenz, H Uno, S Morgello, D Franklin, RJ Ellis, ... Clinical Infectious Diseases 67 (8), 1182-1190, 2018 | 53 | 2018 |
| Electroencephalographic abnormalities are common in COVID‐19 and are associated with outcomes L Lin, A Al‐Faraj, N Ayub, P Bravo, S Das, L Ferlini, I Karakis, JW Lee, ... Annals of neurology 89 (5), 872-883, 2021 | 51 | 2021 |
| Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy D Guha, SS Mukerji, S Chettimada, V Misra, DR Lorenz, S Morgello, ... Aids 33 (4), 615-625, 2019 | 49 | 2019 |
| Delayed activin A administration attenuates tissue death after transient focal cerebral ischemia and is associated with decreased stress‐responsive kinase activation SS Mukerji, RN Rainey, JL Rhodes, AK Hall Journal of neurochemistry 111 (5), 1138-1148, 2009 | 49 | 2009 |
| Highlights of the global HIV-1 CSF escape consortium meeting, 9 June 2016, Bethesda, MD, USA J Joseph, P Cinque, D Colosi, A Dravid, L Ene, H Fox, D Gabuzda, ... Journal of virus eradication 2 (4), 243-250, 2016 | 48 | 2016 |
| CoVA: an acuity score for outpatient screening that predicts coronavirus disease 2019 prognosis H Sun, A Jain, MJ Leone, HS Alabsi, LN Brenner, E Ye, W Ge, YP Shao, ... The Journal of infectious diseases 223 (1), 38-46, 2021 | 45 | 2021 |
| Enhanced virus detection and metagenomic sequencing in patients with meningitis and encephalitis A Piantadosi, SS Mukerji, S Ye, MJ Leone, LM Freimark, D Park, G Adams, ... MBio 12 (4), 10.1128/mbio. 01143-21, 2021 | 42 | 2021 |
| Innate immune signaling in the olfactory epithelium reduces odorant receptor levels: modeling transient smell loss in COVID-19 patients S Rodriguez, L Cao, GT Rickenbacher, EG Benz, C Magdamo, LR Gomez, ... MedRxiv, 2020 | 42 | 2020 |
M. Brandon Westover, MD, PhDHarvard Medical School / Massachusetts General Hospital在 mgh.harvard.edu 的电子邮件经过验证
